companydata.dkSIMULPHARMA ApS: Financial statements 2024
CVR: 32832075
SIMULPHARMA ApS (CVR 32832075) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 158,958 and a net result of DKK 41,292 compared with DKK -57,341 the year before. That is an increase of 38.2% compared with the year before. The profit margin was 26%. Equity amounted to DKK 63,769. The solvency ratio was 83.5%.
- Revenue
- 158,958 kr.
- Gross Profit
- 41,196 kr.
- Profit/Loss
- 41,292 kr.
- Equity
- 63,769 kr.
- Total Assets
- 76,394 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 159 t. | 41 t. | 41 t. | 64 t. | - |
| 2023 | 115 t. | 115 t. | -57 t. | 22 t. | 1 |
| 2022 | 484 t. | 406 t. | -58 t. | 80 t. | 1 |
| 2021 | 636 t. | 636 t. | -83 t. | 138 t. | 1 |
| 2020 | 719 t. | 719 t. | 36 t. | 221 t. | 1 |
How creditworthy is SIMULPHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
SIMULPHARMA ApS has published its annual report for 2023. Revenue came to DKK 114,981, and the net result was DKK -57,341.
About SIMULPHARMA ApS
SIMULPHARMA ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2010. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The management consists of Gunnlaugur Halldorsson. The company is owned by Gunnlaugur Halldorsson. The company has 1 employee. In 2024, the company reported revenue of DKK 158,958 and a net result of DKK 41,292 compared with DKK -57,341 the year before. Equity amounted to DKK 63,769.